Cargando…
Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region
Deletion of 13q14.3 and a candidate gene KCNRG (potassium channel regulating gene) is the most frequent chromosomal abnormality in B-cell chronic lymphocytic leukemia and is a common finding in multiple myeloma (MM). KCNRG protein may interfere with the normal assembly of the K+ channel proteins cau...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803748/ https://www.ncbi.nlm.nih.gov/pubmed/20237900 http://dx.doi.org/10.1007/s13277-009-0005-0 |
_version_ | 1782176065420001280 |
---|---|
author | Birerdinc, Aybike Nohelty, Elizabeth Marakhonov, Andrey Manyam, Ganiraju Panov, Ivan Coon, Stephanie Nikitin, Eugene Skoblov, Mikhail Chandhoke, Vikas Baranova, Ancha |
author_facet | Birerdinc, Aybike Nohelty, Elizabeth Marakhonov, Andrey Manyam, Ganiraju Panov, Ivan Coon, Stephanie Nikitin, Eugene Skoblov, Mikhail Chandhoke, Vikas Baranova, Ancha |
author_sort | Birerdinc, Aybike |
collection | PubMed |
description | Deletion of 13q14.3 and a candidate gene KCNRG (potassium channel regulating gene) is the most frequent chromosomal abnormality in B-cell chronic lymphocytic leukemia and is a common finding in multiple myeloma (MM). KCNRG protein may interfere with the normal assembly of the K+ channel proteins causing the suppression of Kv currents. We aimed to examine possible role of KCNRG haploinsufficiency in chronic lymphocytic leukemia (CLL) and MM cells. We performed detailed genomic analysis of the KCNRG locus; studied effects of the stable overexpression of KCNRG isoforms in RPMI-8226, HL-60, and LnCaP cells; and evaluated relative expression of its transcripts in various human lymphomas. Three MM cell lines and 35 CLL PBL samples were screened for KCNRG mutations. KCNRG exerts growth suppressive and pro-apoptotic effects in HL-60, LnCaP, and RPMI-8226 cells. Direct sequencing of KCNRG exons revealed point mutation delT in RPMI-8226 cell line. Levels of major isoform of KCNRG mRNA are lower in DLBL lymphomas compared to normal PBL samples, while levels of its minor mRNA are decreased across the broad range of the lymphoma types. The haploinsufficiency of KCNRG might be relevant to the progression of CLL and MM at least in a subset of patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13277-009-0005-0) contains supplementary material, which is available to authorized users. |
format | Text |
id | pubmed-2803748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-28037482010-01-22 Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region Birerdinc, Aybike Nohelty, Elizabeth Marakhonov, Andrey Manyam, Ganiraju Panov, Ivan Coon, Stephanie Nikitin, Eugene Skoblov, Mikhail Chandhoke, Vikas Baranova, Ancha Tumour Biol Research Article Deletion of 13q14.3 and a candidate gene KCNRG (potassium channel regulating gene) is the most frequent chromosomal abnormality in B-cell chronic lymphocytic leukemia and is a common finding in multiple myeloma (MM). KCNRG protein may interfere with the normal assembly of the K+ channel proteins causing the suppression of Kv currents. We aimed to examine possible role of KCNRG haploinsufficiency in chronic lymphocytic leukemia (CLL) and MM cells. We performed detailed genomic analysis of the KCNRG locus; studied effects of the stable overexpression of KCNRG isoforms in RPMI-8226, HL-60, and LnCaP cells; and evaluated relative expression of its transcripts in various human lymphomas. Three MM cell lines and 35 CLL PBL samples were screened for KCNRG mutations. KCNRG exerts growth suppressive and pro-apoptotic effects in HL-60, LnCaP, and RPMI-8226 cells. Direct sequencing of KCNRG exons revealed point mutation delT in RPMI-8226 cell line. Levels of major isoform of KCNRG mRNA are lower in DLBL lymphomas compared to normal PBL samples, while levels of its minor mRNA are decreased across the broad range of the lymphoma types. The haploinsufficiency of KCNRG might be relevant to the progression of CLL and MM at least in a subset of patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13277-009-0005-0) contains supplementary material, which is available to authorized users. Springer Netherlands 2009-12-18 /pmc/articles/PMC2803748/ /pubmed/20237900 http://dx.doi.org/10.1007/s13277-009-0005-0 Text en © The Author(s) 2009 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Research Article Birerdinc, Aybike Nohelty, Elizabeth Marakhonov, Andrey Manyam, Ganiraju Panov, Ivan Coon, Stephanie Nikitin, Eugene Skoblov, Mikhail Chandhoke, Vikas Baranova, Ancha Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region |
title | Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region |
title_full | Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region |
title_fullStr | Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region |
title_full_unstemmed | Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region |
title_short | Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region |
title_sort | pro-apoptotic and antiproliferative activity of human kcnrg, a putative tumor suppressor in 13q14 region |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803748/ https://www.ncbi.nlm.nih.gov/pubmed/20237900 http://dx.doi.org/10.1007/s13277-009-0005-0 |
work_keys_str_mv | AT birerdincaybike proapoptoticandantiproliferativeactivityofhumankcnrgaputativetumorsuppressorin13q14region AT noheltyelizabeth proapoptoticandantiproliferativeactivityofhumankcnrgaputativetumorsuppressorin13q14region AT marakhonovandrey proapoptoticandantiproliferativeactivityofhumankcnrgaputativetumorsuppressorin13q14region AT manyamganiraju proapoptoticandantiproliferativeactivityofhumankcnrgaputativetumorsuppressorin13q14region AT panovivan proapoptoticandantiproliferativeactivityofhumankcnrgaputativetumorsuppressorin13q14region AT coonstephanie proapoptoticandantiproliferativeactivityofhumankcnrgaputativetumorsuppressorin13q14region AT nikitineugene proapoptoticandantiproliferativeactivityofhumankcnrgaputativetumorsuppressorin13q14region AT skoblovmikhail proapoptoticandantiproliferativeactivityofhumankcnrgaputativetumorsuppressorin13q14region AT chandhokevikas proapoptoticandantiproliferativeactivityofhumankcnrgaputativetumorsuppressorin13q14region AT baranovaancha proapoptoticandantiproliferativeactivityofhumankcnrgaputativetumorsuppressorin13q14region |